Loading...
Docoh
Log in Free sign up

Petmed Express (PETS)

Founded in 1996, PetMed Express is America's Most Trusted Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its toll free number and on the Internet through its website.

Company profile

Ticker
PETS
Exchange
NASDAQ
Website
www.1800petmeds.com
CEO
Menderes Akdag
Employees
Incorporated
Florida
Location
Florida
Fiscal year end
Mar 31
Sector
Retail Trade > Pharmacies and Drug Stores
Industry (SIC)
Retail - Drug Stores and Proprietary Stores
CVS Health • Walgreens Boots Alliance • Rite Aid • Covetrus • 111 • China Jo-Jo Drugstores • China Jo-Jo Drugstores • Dougherty's Pharmacy • Dragon Jade International • MedAvail ...
SEC CIK
0001040130
Corporate docs
Subsidiaries
Southeastern Veterinary Exports, Inc. • First Image Marketing, Inc. • Global Veterinary Supply, Inc. • 420 South Congress Avenue LLC ...
IRS number
650680967

PETS stock data

News

From Benzinga Pro
12 Consumer Discretionary Stocks Moving In Friday's After-Market Session
5 Aug 22
Gainers
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $19
26 Jul 22
Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $20 to $19.
Petmed Express Shares Plunge On Q1 Earnings Miss
26 Jul 22
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
25 Jul 22
UPDATE: PetMed Express Q1 Adj. EPS $0.14 Misses $0.25 Estimate
25 Jul 22

Press releases

From Benzinga Pro
PetMeds® Announces Its First Quarter Financial Results and Declares a Quarterly Dividend of $0.30 Per Share
25 Jul 22
DELRAY BEACH, Fla., July 25, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS), Your Trusted Pet Health ExpertTM, today announced its financial results for its first quarter ended June 30, 2022. Net sales for
PetMeds® Hires Christine Chambers as Chief Financial Officer
22 Jul 22
Seasoned executive brings a wealth of financial leadership to further accelerate the company's digital transformation. DELRAY BEACH, Fla., July 22, 2022 /PRNewswire-PRWeb/ -- PetMed Express, Inc. (NASDAQ:PETS), Your
PetMeds® Becomes Exclusive US Fulfillment Partner for Pet Telemedicine Platform Vetster
15 Jul 22
Veterinarians practicing on Vetster in the United States can now access PetMeds' full catalog of prescription and select OTC medications giving pet owners fast, convenient nationwide shipping DELRAY BEACH, Fla., July
PetMeds® To Announce Its First Quarter Financial Results On July 25, 2022
11 Jul 22
Shapeways Expands Board of Directors With Appointment of Digital Industry Veteran Raj Batra as Independent Director
6 Jul 22

Analyst ratings and price targets

Last 3 months
Morgan Stanley
Maintains
Underweight
$19.00
26 Jul 22

Calendar

2 Aug 22
12 Aug 22
31 Mar 23

Financial summary

Financial statements Chart PETS financial data
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Mar 22 Mar 21 Mar 20 Mar 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 105.41M 105.41M 105.41M 105.41M 105.41M 105.41M
Cash burn (monthly) 1.89M 531K (no burn) (no burn) (no burn) (no burn)
Cash used (since last report) 2.74M 770.61K n/a n/a n/a n/a
Cash remaining 102.67M 104.64M n/a n/a n/a n/a
Runway (months of cash) 54.4 197.1 n/a n/a n/a n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Recent insider trades

PETS insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
28 Jul 22 Diana G Purcel Common Stock Grant Acquire A No No 21.76 7,500 163.2K 9,375
28 Jul 22 Gian Fulgoni Common Stock Grant Acquire A No No 21.76 7,500 163.2K 68,510
28 Jul 22 Campbell Leslie C.G. Common Stock Grant Acquire A No No 21.76 7,500 163.2K 40,000
28 Jul 22 Jodi Watson Common Stock Grant Acquire A No No 21.76 7,500 163.2K 18,880
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

PETS institutional ownership history Ownership history
81.3% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 181 186 -2.7%
Opened positions 23 23 –
Closed positions 28 36 -22.2%
Increased positions 71 61 +16.4%
Reduced positions 48 55 -12.7%
13F shares Current Prev Q Change
Total value 443.85M 429.01M +3.5%
Total shares 17.07M 16.96M +0.7%
Total puts 851.02K 1.1M -22.5%
Total calls 597.7K 592.6K +0.9%
Total put/call ratio 1.4 1.9 -23.2%
Largest owners Shares Value Change
BLK Blackrock 3.34M $86.12M +1.4%
Vanguard 1.44M $37.08M +2.2%
Renaissance Technologies 972.78K $25.1M +19.1%
ProShare Advisors 914.5K $23.59M -7.6%
STT State Street 913.52K $23.57M -10.6%
Dimensional Fund Advisors 567.33K $14.64M -1.4%
Mirae Asset Global Investments 546.35K $14.1M +46.3%
BNP Paribas Asset Management Holding 532.53K $13.74M -6.1%
Charles Schwab Investment Management 481.17K $12.42M +9.9%
Oaktop Capital Management Ii 445.84K $11.5M 0.0%
Largest transactions Shares Bought/sold Change
Jeneq Management 0 -250K EXIT
Point72 Asset Management 297.91K +205.1K +221.0%
Mirae Asset Global Investments 546.35K +173.03K +46.3%
Renaissance Technologies 972.78K +156.3K +19.1%
STT State Street 913.52K -108.64K -10.6%
Citadel Advisors 220.36K +104.9K +90.9%
GS Goldman Sachs 180.39K +92.77K +105.9%
Penserra Capital Management 338.86K -78.84K -18.9%
ProShare Advisors 914.5K -75.56K -7.6%
Allianz Asset Management GmbH 427.02K -69.18K -13.9%
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: accurate, attainment, AutoShip, behavior, Canadian, CFO, challenging, Christine, colder, criteria, delay, encouraged, ExpertTM, fee, finalizing, FY, gauge, goal, greater, half, heading, impairment, increasingly, integration, launched, law, letter, loyal, methodology, MINE, partnership, post, predict, previously, program, promotion, promotional, proposal, QUALITATIVE, QUANTITATIVE, remotely, repayment, representation, Save, SENIOR, subscription, telemedicine, tied, trend, Trusted, Vetster, weather, workplace
Removed: bank, CEO, competitive, component, crowded, discounting, easier, eliminating, expect, factor, higher, improvement, national, receiving, refund, standard, substantial, substantially, term, understand, work
From filing 10-Q 2023 Q1
Financial reports
View all
10-Q
2023 Q1
Quarterly report
2 Aug 22
10-K
2022 FY
Annual report
24 May 22
10-Q
2021 Q3
Quarterly report
4 Feb 22
10-Q
2022 Q2
Quarterly report
2 Nov 21
10-Q
2022 Q1
Quarterly report
30 Jul 21
10-K
2021 FY
Annual report
25 May 21
10-Q
2021 Q3
Quarterly report
26 Jan 21
10-Q
2021 Q2
Quarterly report
3 Nov 20
10-Q
2021 Q1
Quarterly report
3 Aug 20
10-K
2020 FY
Annual report
26 May 20
Current reports
View all
8-K
Departure of Directors or Certain Officers
3 Aug 22
8-K
Departure of Directors or Certain Officers
2 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
29 Jul 22
8-K
Conference Call Transcript
27 Jul 22
8-K
PetMeds® Announces Its First Quarter Financial Results and Declares a Quarterly Dividend of $0.30 Per Share
26 Jul 22
8-K
Regulation FD Disclosure
18 Jul 22
8-K
Departure of Directors or Certain Officers
14 Jul 22
8-K
Regulation FD Disclosure
11 Jul 22
8-K
Conference Call Transcript
12 May 22
8-K
PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results
10 May 22
Registration and prospectus
View all
424B3
Prospectus supplement
24 Jun 22
424B3
Prospectus supplement
16 Feb 21
424B3
Prospectus supplement
29 Nov 19
S-8
Registration of securities for employees
22 Jun 17
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 17
S-8
Registration of securities for employees
6 Aug 07
S-8
Registration of securities for employees
6 Aug 07
424B3
Prospectus supplement
30 Sep 04
POS AM
Prospectus update (post-effective amendment)
15 Jul 04
424B3
Prospectus supplement
16 Sep 03
Proxies
View all
DEFA14A
Additional proxy soliciting materials
18 Jul 22
DEFA14A
Additional proxy soliciting materials
14 Jul 22
DEF 14A
Definitive proxy
17 Jun 22
DEF 14A
Definitive proxy
17 Jun 21
DEF 14A
Definitive proxy
19 Jun 20
DEFA14A
Additional proxy soliciting materials
17 Jul 19
DEFR14A
Revised proxy
10 Jul 19
DEF 14A
Definitive proxy
14 Jun 19
PRE 14A
Preliminary proxy
4 Jun 19
DEF 14A
Definitive proxy
11 Jun 18
Other
View all
UPLOAD
Letter from SEC
27 Feb 11
CORRESP
Correspondence with SEC
24 Feb 11
UPLOAD
Letter from SEC
15 Feb 11
UPLOAD
Letter from SEC
23 Aug 09
CORRESP
Correspondence with SEC
6 Aug 09
UPLOAD
Letter from SEC
16 Jul 09
CORRESP
Correspondence with SEC
7 Jun 09
CORRESP
Correspondence with SEC
19 May 09
UPLOAD
Letter from SEC
10 May 09
CORRESP
Correspondence with SEC
14 Apr 09
Ownership
View all
3
PETMED EXPRESS / Christine Chambers ownership change
10 Aug 22
4
PETMED EXPRESS / Peter Cobb ownership change
1 Aug 22
4
PETMED EXPRESS / Leslie C.G. Campbell ownership change
1 Aug 22
4
PETMED EXPRESS / Jodi Watson ownership change
1 Aug 22
4
PETMED EXPRESS / GIAN FULGONI ownership change
1 Aug 22
4
PETMED EXPRESS / DIANA G PURCEL ownership change
1 Aug 22
3
PETMED EXPRESS / Carolyn Carden ownership change
17 May 22
3
PETMED EXPRESS / DIANA G PURCEL ownership change
4 Apr 22
SC 13G/A
PETMED EXPRESS / RENAISSANCE TECHNOLOGIES ownership change
10 Feb 22
SC 13G
PETMED EXPRESS / ProShare Advisors ownership change
10 Feb 22

Transcripts

View all
2022 Q1
Earnings call transcript
26 Jul 22
2021 Q4
Earnings call transcript
10 May 22
2021 Q3
Earnings call transcript
25 Jan 22
2022 Q2
Earnings call transcript
26 Oct 21
2021 Q1
Earnings call transcript
26 Jul 21
2020 Q4
Earnings call transcript
3 May 21
2020 Q3
Earnings call transcript
19 Jan 21
2020 Q2
Earnings call transcript
26 Oct 20
2020 Q1
Earnings call transcript
20 Jul 20
2019 Q4
Earnings call transcript
4 May 20

Reddit threads

View all